SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

   Biotech / MedicalGeron Corp.


Previous 10 Next 10 
From: tktrimbath3/13/2024 1:03:00 PM
   of 3566
 
We/Geron/GERN almost had good news?
statnews.com

Share RecommendKeepReplyMark as Last Read


From: tktrimbath3/14/2024 7:25:08 PM
1 Recommendation   of 3566
 
Yay. Whew. Good news.

"The panel, by a wide 12-to-2 margin, voted in favor of the benefits of the injectable drug, called imetelstat, stating the associated risks and toxicities of the treatment appear to be manageable."

reuters.com

Share RecommendKeepReplyMark as Last ReadRead Replies (2)


To: tktrimbath who wrote (3556)3/15/2024 3:45:38 PM
From: cycleupcycledown
   of 3566
 
Outside chance becomes a meme stock, efficacy on many fronts…..cracked the telomeres code.

Share RecommendKeepReplyMark as Last Read


To: tktrimbath who wrote (3556)3/15/2024 5:33:50 PM
From: Savant
   of 3566
 
wonder why 2 of the panelists voted against....conflict of interest??

PS...how interesting that the pps took a plunge coupla days ahead of the vote....have seen that before of other cos...

PPS...not a done deal yet, though could go well

Share RecommendKeepReplyMark as Last ReadRead Replies (1)


To: Savant who wrote (3558)3/15/2024 9:39:28 PM
From: tktrimbath
   of 3566
 
I think one or two voted against based on safety concerns.
I think that was released (leaked?) early which may explain the dip.

Share RecommendKeepReplyMark as Last Read


From: cycleupcycledown3/15/2024 9:54:14 PM
   of 3566
 
Article today said Imetelstat reached primary endpoint in phase 3 imerge trial. Is that new news? I haven’t been keeping up….never mind, looked it up, old news

Share RecommendKeepReplyMark as Last ReadRead Replies (1)


To: cycleupcycledown who wrote (3560)3/15/2024 11:19:58 PM
From: tktrimbath
2 Recommendations   of 3566
 
Warning: I rarely get biotech nomenclature right, except by chance but,
An Advisory Panel is advising the FDA to approve (circa June/July 2024) - I think.

Share RecommendKeepReplyMark as Last ReadRead Replies (1)


To: tktrimbath who wrote (3561)4/14/2024 11:19:54 PM
From: cycleupcycledown
1 Recommendation   of 3566
 
Yes sir….Im on it, not sure how I’m going to play it….IF she does a quick spike, don’t know if I’ll cash, or hold “old turkey” for months

Share RecommendKeepReplyMark as Last Read


From: tktrimbath5/21/2024 11:17:47 AM
   of 3566
 
Sold my house. Bought a more affordable one.

Bought a bit of:

$GERN

(The longer story is at https://trimbathcreative.net/2024/05/17/time-to-buy-but-what/)

Share RecommendKeepReplyMark as Last Read


From: tktrimbath6/7/2024 11:11:09 AM
1 Recommendation   of 3566
 
Geron gets approval.

From BusinessWire;
"Geron Announces FDA Approval of RYTELO™ (imetelstat), a First-in-Class Telomerase Inhibitor, for the Treatment of Adult Patients with Lower-Risk MDS with Transfusion-Dependent Anemia"
businesswire.com

Share RecommendKeepReplyMark as Last ReadRead Replies (1)
Previous 10 Next 10